Richa Saxena
Has grant
Professor of Anaesthesia
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Ethical, multimodal AI tool for prediction of preeclampsia risk in early pregnancy
Open Date: 2025-09-01
Close Date: 2026-08-31
Grant: Open
Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study
Open Date: 2024-07-01
Close Date: 2029-04-30
Grant: Open
Modulation of sensitivity to light as a mechanism for antidepressant treatment efficacy
Open Date: 2023-11-01
Close Date: 2029-09-30
Grant: Close
Circadian photoreceptor sensitivity and impacts of modern lighting on sleep
Open Date: 2023-04-24
Close Date: 2026-04-23
Grant: Open
Long COVID as a putative subtype of chronic fatigue syndrome
Open Date: 2022-08-18
Close Date: 2027-07-31
Articles (20)
Objective We examined whether meal timing is associated with long‐term weight‐loss maintenance and whether meal timing interacts with a genome‐wide polygenic score (PRS‐BMI) on body weight‐related outcomes. We then examined the interaction of meal timing with 97 BMI‐related single‐nucleotide polymorphisms on obesity outcome. Methods Participants ( N = 1195, mean age 41.07 [SD 12.68] years, female 80.8%, baseline mean BMI 31.32 [SD 5.53] kg/m 2 ) were adults with overweight or obesity from the Obesity, Nutrigenetics, Timing, and Mediterranean (ONTIME) study. We developed a PRS‐BMI to assess the genetic risk for obesity and estimated the timing of the midpoint of meal intake. We also calculated the success in long‐term weight‐loss maintenance after a dietary obesity treatment (at least 3 years). Linear regression analyses were performed for association and interaction assessments. Results Each hour of delay in meal timing was associated with 2.2% higher long‐term body weight (β [SE] = 2.177% [1.067%]; p = 0.042) (i.e., with lower weight‐loss maintenance following dietary obesity treatment). There was a significant interaction between meal timing and PRS‐BMI ( p = 0.008); BMI increased by more than 2 kg/m 2 for every hour of delay in meal timing in individuals with high PRS‐BMI (β [SE] = 2.208 [0.502] kg/m 2 ; p = 1.0E‐5), whereas no associations were evident for those with lower genetic risk. Conclusions Meal timing is associated with weight‐loss maintenance and may influence the association between obesity genetics and BMI. Findings underscore the importance of personalized obesity management. image
Year:
2025
Objective In this cross‐sectional study, we aim to investigate the interactions between obesity, siesta behavior, and the genetic propensity for siesta in a Mediterranean population, in whom siesta is deeply rooted. Methods We applied a previously generated Siesta‐Polygenic Score (PGS) in the ONTIME study ( n = 1278). Siesta and other Mediterranean lifestyle behaviors were characterized using questionnaires. We further determined obesity grade. Secondarily, we measured weight loss during treatment as well as long‐term weight‐loss maintenance. Logistic regression analyses were performed to address our aim. Results A total of 42.4% of the population usually took siesta. A significant genetic influence on siesta propensity was found, with a higher genetic predisposition linked to taking siesta more frequently (odds ratio [OR] = 1.17, 95% CI: 1.03–1.32; p = 0.015). Participants with a higher genetic propensity for siesta showed poorer dietary habits ( p < 0.05). Among individuals with a high genetic propensity for siesta, we found that those who usually take siesta have lower odds of having obesity ( p = 0.038) compared with those who do not. Similarly, in exploratory analysis, among individuals with a high genetic propensity for siesta, we found that those who usually take siesta have higher odds of weight‐loss success ( p = 0.007) compared with those who do not. Conclusions Considering the ongoing debate regarding whether siesta is beneficial or detrimental, our findings suggest that individual genetic predisposition to siesta might influence the association between siesta and health. image
Year:
2025
Insomnia symptoms double the risk of cardiovascular disease (CVD), yet shared genetic pathways remain unclear. Genome-wide association studies identified a genetic locus (near ATP5G1, UBE2Z, SNF8, IGF2BP1 and GIP) linked to insomnia and CVD. We used Drosophila models to perform tissue-specific RNA interference knockdowns of four conserved orthologs (ATPsynC, lsn, Bruce and Imp) in neurons and the heart. Neuronal-specific knockdown of ATPsynC, Imp and lsn impaired sleep quantity and quality. In contrast, cardiac knockdown of ATPsynC and lsn reduced cardiac function and lifespan, with lsn knockdown also causing cardiac dilation and myofibrillar disorganization. Cross-tissue effects were evident: neuronal Imp knockdown compromised cardiac function, whereas cardiac ATPsynC and lsn knockdown increased sleep fragmentation and inflammation (marked by Upd3 elevation in the heart or head). Overexpression of Upd3 in neurons impaired cardiac function, and its overexpression in the heart disrupted sleep. Our findings reveal conserved genes mediating tissue-specific and cross-tissue interactions between sleep and cardiac function, providing novel insights into the genetic mechanisms linking insomnia and CVD through inflammation.
Year:
2025
Study Objectives Excessive daytime sleepiness (EDS), influenced by environmental and social-behavioral factors, is reported by a subset of patients with sleep apnea—a group that may be at elevated cardiovascular risk. However, it is unclear whether sleep apnea with and without EDS have distinct genetic underpinnings. In this study, we perform gene-by-EDS interaction analyses for apnea hypopnea index, a diagnostic marker of sleep apnea severity, to understand EDS’s influence on its underlying genetic risk. Methods Discovery interaction analyses for common variants and gene-based rare variants were conducted respectively using multi-ethnic Trans-Omics for Precision Medicine (N = 11 619) data, followed by replication and subsequent meta-analysis in additional Trans-Omics for Precision Medicine-imputed data (N = 8904). The 1 degree-of-freedom (1df) G × E test and the 2df joint G,G × E tests were utilized. Sex-stratified analyses were additionally performed. Results Discovery analysis revealed two common intronic variants—rs13118183 (CCDC3) and rs281851 (MARCHF1)—and three rare variant gene sets mapped to SCUBE2, TMEM26, and CPS4FL—to exhibit interaction with EDS. Meta-analysis revealed EDS interaction with 11 rare variant gene sets mapped to UBLCP1, MED31, RAP1GAP, CPNE5, MYMX, YY1, ZNF773, YBEY, IQCB1, PI4K2B, and CORO1A. Conclusion Genetic loci reveal connections to cardiovascular risk, insulin resistance, thiamine deficiency, and resveratrol mechanism. Discovered genetic signals may offer insight into pertinent biological pathways for sleep apnea patients with an excessively sleepy subtype. Statement of Significance Sleep apnea is a complex sleep disorder. Exemplifying this is the disparately varying estimates of presence of excessive daytime sleepiness (EDS) in patients, and persistent EDS that lingers despite treatment. Some data indicate that the excessively sleepy subtype of sleep apnea carries heightened cardiovascular risk. Whether EDS influences genetic risk factors underlying sleep apnea has not yet been investigated. This study addresses this gap, as the first genome-wide gene × EDS interaction study for apnea hypopnea index, the standard sleep apnea severity metric. Genetic loci that have been previously unconsidered for sleep apnea are revealed. Discovered interaction signals highlight pathways in metabolism, genes associated with cardiometabolic traits, and therapeutic agents influencing obesity, blood pressure, oxidative stress, and apnea hypopnea index.
Year:
2025
Aims/hypothesis Suboptimal sleep health is linked to higher risks for incident type 2 diabetes. We aimed to assess the clinical utility of adding self-reported sleep traits to a type 2 diabetes prediction model. Methods In this cohort study, we used UK Biobank data and Cox proportional hazards models to examine how self-reported sleep duration and insomnia symptoms were associated with incident type 2 diabetes risk. Harrell’s C statistic and net reclassification improvement (NRI) were used to assess whether sleep traits improved the incident type 2 diabetes discrimination and predictive utility achieved using QDiabetes variables, with and without including a type 2 diabetes polygenic risk score (PGS). Independent replication was explored in the Nurses’ Health Study, the Nurses’ Health Study II and the Health Professionals Follow-up Study. Results Extremes of sleep duration and occasional or frequent insomnia symptoms were associated with higher risks for incident type 2 diabetes. In the UK Biobank and replication cohorts, adding sleep traits to the QDiabetes risk score did not improve type 2 diabetes prediction (C statistic: QDiabetes alone 0.8933; QDiabetes + sleep duration 0.8939; QDiabetes + insomnia 0.8931; QDiabetes + sleep traits 0.8935). The corresponding total NRI values were: 0.08 (95% CI −0.18, 0.33), 0.04 (95% CI −0.08, 0.16) and 0.04 (95% CI −0.10, 0.18). Inclusion of PGS data marginally improved the type 2 diabetes risk prediction achieved using The QDiabetes calculator, with or without the inclusion of sleep traits in the model (QDiabetes + PGS: C statistic 0.8945; total NRI 0.20 [95% CI 0.12, 0.28]; QDiabetes + PGS + sleep traits: C statistic 0.8946; total NRI 0.18 [95% CI 0.09, 0.27]). Conclusions/interpretation While sleep duration and insomnia symptoms were associated with type 2 diabetes risk, they are not useful for improving type 2 diabetes prediction beyond QDiabetes model performance. Inclusion of a type 2 diabetes PGS marginally improved prediction but lacked clear clinical utility. Graphical Abstract
Year:
2025
Year:
2025
Year:
2025
Background Sleep apnoea is a common sleep disorder affecting at least 10% of the population. It is caused by lack of breathing during sleep, typically mediated by obstruction of airways or less frequently by misdirected central signals for breathing. The primary risk factor is a high body mass index, causing airway obstruction. However, understanding risk factors for sleep apnoea in non-obese (body mass index 0.8), and single-cell sequencing implicated HTR1F expression, particularly in neurons. Analysis of expression quantitative trait locus data further supported a possible regulatory role in neurons (β= −0.03, p=1.2×10 −4 ). Finally, phenome-wide association study analysis of rs1818163 showed an association with objectively measured sleep-activity data, specifically with the number of awakenings during the night (p=5.6×10 −8 ). Conclusions The findings indicate that HTR1F is associated with sleep apnoea, particularly in the non-obese patient population, and provide insight into the growing evidence of serotonin signalling as a factor modulating liability to sleep apnoea.
Year:
2025
Modern lifestyles often disturb circadian rhythms, yet the genetic circuits that convert this stress into metabolic dysfunction remain poorly defined. Here, we identify a missense variant in ADCY3 (rs11676272; Ser107Pro) as a pleiotropic regulator of circadian preference and adiposity. Using genome-wide pleiotropy analysis in ∼480,000 UK Biobank participants, we show that the G risk allele (Pro107) increases morningness, BMI, and fat mass in European (N=451,324) and African (N=8,738) ancestry groups, with behavioral amplification by morning difficulty awakening observed in Europeans, power limited interaction modeling in other populations. Structural modeling and transcriptomic analysis suggest this allele destabilizes ADCY3 and alters adipose-specific splicing and expression. In mice, Adcy3 is rhythmically expressed in adipose tissue, with the conserved Pro107 site showing BMAL1 binding and cold-inducible activation. Human adipose ADCY3 expression also increases after weight loss. Together, these findings reveal a genotype-dependent, behaviorally modifiable axis linking difficulty awakening to adipose thermogenesis and obesity risk.
Year:
2025
Study Objectives Chronotype, a manifestation of circadian rhythms, affects morning or evening preferences and ease of getting up. This study explores the genetic basis of morning chronotype and ease of getting up, focusing on the G-protein-coupled receptor locus, GPR61. Methods We analyzed the genetic correlation between chronotype and ease of getting up using linkage disequilibrium score regression with summary statistics from the UK Biobank (n = 453,379). We prioritized shared signals between chronotype and ease of getting up using the Human Genetic Evidence (HuGE) score. We assessed the significance of GPR61 and the lead variant rs12044778 through co-localization and in silico analyses from ENCODE, Genotype-Tissue Expression, Hi-C, and Knockout Mouse Project databases to explore potential regulatory roles of causal genes. Results We identified a strong genetic correlation (Rg = 0.80, p = 4.9 × 10324) between chronotype and ease of getting up. Twenty-three genes, including three circadian core clock components, had high HuGE scores for both traits. Lead variant rs12044778 in GPR61 was prioritized for its high HuGE score (45) and causal pleiotropy (posterior probability = 0.98). This morningness variant influenced gene expression in key tissues: decreasing GPR61 in tibial nerve, increasing AMIGO1 in subcutaneous adipose, and increasing ATXN7L2 in the cerebellum. Functional knockout models showed GPR61 knockout increased fat mass and activity, AMIGO1 knockout increased activity, and ATXN7L2 knockout reduced body weight without affecting activity. Conclusions Our findings reveal pleiotropic genetic factors influencing chronotype and ease of getting up, emphasizing GPR61’s rs12044778 and nearby genes like AMIGO1 and ATXN7L2. These insights advance our understanding of circadian preferences and suggest potential therapeutic interventions.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Collaborators (42)
Hanna Ollila
University of Helsinki
Renato Polimanti
Yale University School of Medicine
Jonathan K Pritchard
Stanford University
Marta Garaulet
Professor of Physiology and Nutrition
Universidad de Murcia
Tuula Palotie
University of Helsinki
Laura Raffield
Assistant Professor
University of North Carolina at Chapel Hill
David Ray
Professor of Endocrinology
University of Oxford
Priit Palta
Professor of Translational Genomics
University of Tartu
Simon Kyle
Professor
University of Oxford
Girish Melkani
The University of Alabama
Han Chen
Professor
NYU School of Medicine
Tian Ge
Broad Institute
Lyle John Palmer
Professor
University of Adelaide
Timothy Frayling
NHS research training fellow, Lecturer, Senior Lecturer, Professor
University of Exeter
Stephanie Zellers
University of Helsinki
Aarno Palotie
University of Helsinki
Michael N Weedon
Associate Professor
University of Exeter Medical School
Nasa Sinnott-Armstrong
Assistant Professor
Fred Hutch Cancer Center
Lea Urpa
University of Helsinki
Aurora Aragón-Alonso
Associate Professor
Universidad de Murcia
Frank Scheer
Associate Member
Broad Institute
Martin Rutter
Professor of Cardiometabolic Medicine
The University of Manchester
Rocío Jiménez de la Peña Armada
Assistant Professor
Universidad Complutense de Madrid
Andrew Wood
Lecturer in Statistical Genetics and Health Data Science
University of Exeter
Jacqueline Lane
Assistant Professor
Brigham and Women's Hospital
Victoria Garfield
Senior Lecturer
University of Liverpool
James Walker
Assistant Professor
Massachusetts General Hospital
Hassan Dashti
Assistant Professor
Broad Institute
Adel Bachour
University of Helsinki
Martin Broberg
University of Helsinki
Samuli Ripatti
University of Helsinki
Andrew Phillips
MONASH UNIVERSITY
Brian Cade
Investigator
Brigham and Women's Hospital
SINA A. GHARIB
University of Washington
Diego Salmerón Martínez
Universidad de Murcia
Tianyi Huang
Tenure-Track Investigator
National Institute on Aging
Jaakko Kaprio
Research Director
University of Helsinki
Alison Wright
The University of Manchester
Sean Cain
Professor
Flinders University
Jukka Koskela
University of Helsinki
Sutapa Mukherjee
Flinders University
ANA ISABEL CASCALES SÁNCHEZ
Profesora en el Grado de Nutrición Humana y Dietética
Universidad de Murcia
Make your next move.
Prepare your application
Review drafts before you send them.